Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer
Publication:2659871
DOI10.1016/j.jtbi.2020.110570zbMath1460.92100OpenAlexW3120359396MaRDI QIDQ2659871
Yang Kuang, Sharon M. Crook, Eric J. Kostelich, Kyle Nguyen, Tin Phan, Trevor Reckell
Publication date: 29 March 2021
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2020.110570
pharmacokineticsadaptive therapyoptimal treatment scheduledrug effectsandrogen dynamicsintermittent androgen deprivation therapyhormonal therapyprostate cancer modeling
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)
Related Items (1)
Uses Software
Cites Work
- Unnamed Item
- Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer
- Variance based sensitivity analysis of model output. Design and estimator for the total sensitivity index
- A mathematical model of prostate tumor growth and androgen-independent relapse
- Making best use of model evaluations to compute sensitivity indices
- Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer
- Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
- Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy
- Modeling the effect of immunotherapies on human castration-resistant prostate cancer
- Practically scheduling hormone therapy for prostate cancer using a mathematical model
- Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis
- Optimal control of multiplicative control systems arising from cancer therapy
- Parameter Selection and Verification Techniques Based on Global Sensitivity Analysis Illustrated for an HIV Model
- Global sensitivity indices for nonlinear mathematical models and their Monte Carlo estimates
This page was built for publication: Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer
